vimarsana.com
Home
Live Updates
Theriva™ Biologics to Present Preclinical Data Suppor
Theriva™ Biologics to Present Preclinical Data Suppor
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human pancreatic mouse xenograft– – The observed synergy emphasizes...
Related Keywords
United States ,
American ,
Sheila Connelly ,
Theriva Biologics ,
Stevena Shallcross ,
Chris Calabrese ,
Lifesci Advisors ,
Biologics Inc ,
Company Annual Report On Form ,
Globenewswire Inc ,
American Society For Cell ,
Theriva Biologics Inc ,
Gene Therapy ,
Annual Meeting ,
Chief Executive Officer ,
Enhanced Anti Tumor Efficacy ,
Combination Therapy ,
Oncolytic Adenovirus ,
Liposomal Irinotecan ,
Human Pancreatic Mouse ,
Vice President ,
Session Date ,
Theriva Biologic ,
Private Securities Litigation Reform Act ,
Annual Report ,
Sci Advisors ,
Markets ,